ArticleGlobal health action2025
Implementation protocol for a treatment bundle targeting modifiable risk factors for preterm birth.
Article in Global health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preterm birth (PTB) is the main cause of perinatal and neonatal morbidity and mortality worldwide. Widespread implementation of guidelines for early identification and management of patients at risk for adverse pregnancy outcomes is still feeble. This work aims to implement a simple and low-cost bundle to access and manage major modifiable risk factors for PTB. We included first trimester pregnant women seen at Health Units from Jaú - SP, Brazil, where PTB prevalence ranges from 13,4% to 18%. The protocol is based on three aspects: a questionnaire to access smoking status and clinical history; Gram staining and of vaginal microbiota evaluation using Nugent's criteria and evaluation of cervical infections; and transvaginal ultrasound. Pregnant women who smoke and are willing to quit will be treated with auricular acupuncture and referred to a support group if necessary. All patients will be advised on intimate hygiene habits, and those with dysbiosis will be treated. Cervical length will be accessed using transvaginal ultrasound, and those diagnosed with cervical shortening will be treated with vaginal progesterone. This study highlights the importance of implementing active measures to reduce PTB risk factors in a high prevalence setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.